As is well-known by now, health insurance premiums, especially on the reform law exchanges, are beginning to rise more rapidly. The obvious cause for this is more use of medical services. An analysis from consulting and policy firm Avalere examines what service categories are contributing to the increase in premiums. (Avalere Report) Avalere examined rate filings in nine states, mostly mid-Atlantic and Northeast, for the individual and small group markets. These rate filings contain the insurers justifications for the requested premiums. Six categories of cost were examined, inpatient, outpatient hospital, professional services, drugs, capitation payments and other. The 2017 filings were compared to those for 2016 and to actual expenses in 2015. Given all the hubbub about drug prices, particularly for specialty medications, it was a little surprising to learn that the largest contributor to premium increases for 2017 will be outpatient services, although given what hospitals are doing in the outpatient arena, maybe it shouldn’t be surprising. Although the trends vary by state, overall outpatient spending accounts for 30% of rate increase justifications. The outpatient category represents 27% of actual spending in 2015. Both the contribution to premium increases and to actual health plan costs was similar to that in earlier years. In 2015 plans spend 18% of premiums on prescription medications, and they account for 14% of premium growth in 2017 filings. Inpatient hospital is 20% of spending, but only a 15% contributor to 2017 rate rises. Other, which includes lab, radiology and other miscellaneous services, is only 5% of spending but is growing more rapidly, accounting for 10% of the premium increase. These state filings give a very good sense of where health plans are actually seeing cost increases, whether due to unit prices or utilization, and also often give utilization data.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Reciprocal Trade Barriers
February 13, 2025
Reciprocal Trade Barriers
Trump's imposition of reciprocal tariffs is briliant, exposing the hypocrisy of other countries that have…
Commentary
We Are Truly F**ked
February 12, 2025
We Are Truly F**ked
A bad inflation report, a bad deficit report, a bad ten-year US note auction; Trump…
Commentary
Private Equity Ownership and Health Care Prices
February 12, 2025
Private Equity Ownership and Health Care Prices
Financial investor ownership of health care providers results in higher prices.